Hydralazine IV Dosing for Severe Hypertension in Pregnancy
Administer intravenous hydralazine 5 mg as an initial bolus, repeated every 15-20 minutes up to a maximum of 5 doses (total 25 mg) until target blood pressure is achieved. 1, 2
Standard Dosing Protocol
The evidence-based approach for IV hydralazine in pregnant women with severe hypertension (BP ≥160/110 mmHg) at 34 weeks follows this algorithm:
Initial Dose and Repetition
- First dose: 5 mg IV bolus
- Subsequent doses: 5-10 mg IV every 15-20 minutes
- Maximum: 5 total doses (up to 25 mg total if using 5 mg doses, or up to 40 mg if escalating to 10 mg doses) 2, 3
The FDA label specifies the usual dose range as 20-40 mg repeated as necessary, though obstetric protocols typically use more conservative 5 mg increments 2.
Timing Requirements
Treatment must be initiated within 60 minutes of the first severe hypertension reading to prevent maternal morbidity including intracerebral hemorrhage 1, 4. This is a critical quality metric—do not wait for a confirmatory reading before starting treatment.
Target Blood Pressure
- Reduce mean arterial pressure to <125 mmHg 3
- Achieve systolic BP <160 mmHg and diastolic BP ≤100-110 mmHg 5
- Avoid excessive reduction: Do not drop systolic BP by >80 mmHg or reduce MAP by >25% from baseline, as this risks compromising cerebral autoregulation and uteroplacental perfusion 6
Efficacy Data
Research demonstrates that:
- First 5 mg bolus reduces mean arterial pressure by approximately 12 mmHg 3
- Second bolus reduces MAP by an additional 9 mmHg 3
- Third bolus reduces MAP by approximately 5 mmHg 3
- Blood pressure control is achieved with bolus therapy alone in 89% of cases when protocol is followed 3
Hydralazine produces comparable efficacy to IV labetalol and oral nifedipine, with median time to target BP of 40 minutes 5, 7.
Important Clinical Considerations
When to Stop or Switch
- If target BP is not achieved after 5 doses, switch to an alternative agent (labetalol or nifedipine) 1
- Blood pressure typically begins falling within minutes, with maximal effect at 10-80 minutes 2
Monitoring Requirements
- Check BP every 5-15 minutes during treatment
- Monitor for maternal side effects: palpitations and tachycardia occur more frequently with hydralazine than labetalol 8
- Watch for excessive BP reduction that could compromise cerebral or uteroplacental perfusion
Pitfalls to Avoid
- Do not delay treatment waiting for repeat BP confirmation—the 60-minute window starts from the first severe reading 1
- Do not use discolored solutions—hydralazine discolors on contact with metal 2
- Do not add to infusion solutions—use only as direct IV bolus 2
- Patients with marked renal damage may require lower doses 2
Alternative First-Line Options
If IV access is unavailable or hydralazine is contraindicated, alternatives include:
- IV labetalol: 20 mg, then 40 mg, then 80 mg every 10-20 minutes (max 300 mg) 1
- Oral immediate-release nifedipine: 10-20 mg every 20 minutes 1, 4
Most patients can transition to oral antihypertensive therapy within 24-48 hours 2.